Enalapril
Concept
Vocabulary Service
Overview
subject area of
-
A Prospective Comparison of Four Study Designs Used in Assessing Safety and Effectiveness of Drug Therapy in Hypertension Management Academic Article
-
Abnormal renal medullary response to angiotensin II in SHR is corrected by long-term enalapril treatment Academic Article
-
Acute Precipitants of Congestive Heart Failure Exacerbations Academic Article
-
Acute and long-term effects of the angiotensin-converting enzyme inhibitor, enalapril, on adrenergic activity and sensitivity during exercise in patients with left ventricular systolic dysfunction Academic Article
-
Angiotensin Converting Enzyme Inhibitor Dialyzability and Outcomes in Older Patients Receiving Hemodialysis Academic Article
-
Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction Academic Article
-
Angiotensin-converting enzyme inhibitor-induced angioedema: Still unrecognized Academic Article
-
Baseline Quality of Life as a Predictor of Mortality and Hospitalization in 5,025 Patients With Congestive Heart Failure Academic Article
-
Candesartan cilexetil is not associated with cough in hypertensive patients with enalapril-induced cough Academic Article
-
Clinical characteristics of patients in Studies of Left Ventricular Dysfunction (SOLVD) Academic Article
-
Comparative Effects of Losartan and Enalapril on Exercise Capacity and Clinical Status in Patients With Heart Failure fn1fn1This study was supported by a grant from Merck Research Laboratories, West Point, Pennsylvania. Academic Article
-
Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure Academic Article
-
Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart Failure Academic Article
-
Diabetes mellitus, a predictor of morbidity and mortality in the studies of left ventricular dysfunction (SOLVD) trials and registry Academic Article
-
Early Versus Delayed Enalapril in Patients With Left Ventricular Systolic Dysfunction: Impact on Morbidity and Mortality 15 Years After the SOLVD Trial Academic Article
-
Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions Academic Article
-
Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure Academic Article
-
Effect of comorbidities on outcomes and angiotensin converting enzyme inhibitor effects in patients with predominantly left ventricular dysfunction and heart failure Academic Article
-
Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study Academic Article
-
Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions Academic Article
-
Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction Academic Article
-
Effectiveness of preload reserve as a determinant of clinical status in patients with left ventricular systolic dysfunction Academic Article
-
Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blocker Academic Article
-
Effects of long term cholesterol lowering on coronary atherosclerosis in patient risk factor subgroups: the Simvastatin/enalapril Coronary Atherosclerosis Trial (SCAT). Academic Article
-
Effects of long-term enalapril therapy on left ventricular diastolic properties in patients with depressed ejection fraction. SOLVD Investigators. Academic Article
-
Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators. Academic Article
-
Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators. Academic Article
-
Enalapril prevents clinical proteinuria in diabetic patients with low ejection fraction. Academic Article
-
Fatal neonatal renal failure due to maternal enalapril ingestion Academic Article
-
Felodipine–metoprolol combination tablet: a valuable option to initiate antihypertensive therapy? Academic Article
-
Initial blood pressure response to enalapril in hospitalized patients (studies of left ventricular dysfunction [SOLVD]) Academic Article
-
Involvement of NK1 and NK2 Receptors in Pulmonary Responses Elicited by Non-adrenergic, Non-cholinergic Vagal Stimulation in Guinea-pigs Academic Article
-
Lack of long-term ventricular arrhythmia reduction by enalapril in heart failure Academic Article
-
Long-Term Effects of Cholesterol Lowering and Angiotensin-Converting Enzyme Inhibition on Coronary Atherosclerosis Academic Article
-
Patterns of angiotensin-converting enzyme inhibitor prescriptions, educational interventions, and outcomes among hospitalized patients with heart failure Academic Article
-
Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: Putting guidelines into practice Academic Article
-
Prognostic Significance of Plasma Norepinephrine in Patients With Asymptomatic Left Ventricular Dysfunction Academic Article
-
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study Academic Article
-
Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: The studies of left ventricular dysfunction Academic Article
-
Rationale and design features of a clinical trial examining the effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT). SCAT Investigators. Academic Article
-
Reduced mortality and morbidity with the use of angiotensin-converting enzyme inhibitors in patients with left ventricular dysfunction and congestive heart failure. Academic Article
-
Reliability, validity, and responsiveness of the six-minute walk test in patients with heart failure Academic Article
-
Studies of Left Ventricular Dysfunction (SOLVD)—Rationale, design and methods: Two trials that evaluate the effect of enalapril in patients with reduced ejection fraction Academic Article
-
The relevance of subgroup-specific treatment effects: The Studies Of Left Ventricular Dysfunction (SOLVD) revisited Academic Article
-
Tolerability of enalapril initiation by patients with left ventricular dysfunction: Results of the medication challenge phase of the studies of left ventricular dysfunction Academic Article
-
Usefulness of Temporal Changes in Neurohormones as Markers of Ventricular Remodeling and Prognosis in Patients With Left Ventricular Systolic Dysfunction and Heart Failure Receiving Either Candesartan or Enalapril or Both Academic Article